Therefore, the potent gallbladder-specific CCKAR-selective agonist is likely to offer a new strategy for preventing gallstone formation by increasing gallbladder emptying in women during pregnancy and in individuals with impaired gallbladder contractility. This evidence concerns the gene CCKAR and gallstones.